Adial Pharmaceuticals, Inc. Deferred Income Tax Liabilities, Net
Adial Pharmaceuticals, Inc. (ADIL) had Deferred Income Tax Liabilities, Net of $22.90 thousand as of 2023-03-31, per its 10-Q filed 2023-05-12.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2023-11-14
- 2023-03-31: Deferred Income Tax Liabilities, Net $22.90K.
- 2022-12-31: Deferred Income Tax Liabilities, Net $1.69K; Deferred Income Tax Liabilities, Net as first filed $22.90K.
- 2022-09-30: Deferred Income Tax Liabilities, Net $23.40K.
- 2022-06-30: Deferred Income Tax Liabilities, Net $23.40K.
| Period end | Deferred Income Tax Liabilities, Net | Deferred Income Tax Liabilities, Net as first filed |
|---|---|---|
| 2023-03-31 | $22.90K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $1.69K 10-Q · filed 2023-11-14 | $22.90K 10-K · filed 2023-03-30 |
| 2022-09-30 | $23.40K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $23.40K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $23.40K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $23.40K 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |